Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.93 USD | -0.90% | +4.09% | -1.29% |
02/05 | Transcript : Vir Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
02/05 | Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q1 Revenue $56.4M, vs. Street Est of $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.29% | 136.33Cr | |
+33.37% | 4.95TCr | |
+1.55% | 4.26TCr | |
+49.11% | 4.25TCr | |
-4.22% | 2.91TCr | |
+11.57% | 2.66TCr | |
-21.00% | 1.86TCr | |
+7.36% | 1.32TCr | |
+28.30% | 1.25TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Goldman Sachs Upgrades Vir Biotechnology to Buy From Neutral, Adjusts Price Target to $53 From $41